Size characterization of lipid-based self-emulsifying pharmaceutical excipients during lipolysis using Taylor dispersion analysis with fluorescence detection.
暂无分享,去创建一个
Vincent Jannin | Jean-Christophe Rossi | H. Cottet | V. Jannin | F. Demarne | Joseph Chamieh | Frédéric Demarne | Hervé Cottet | Habib Merdassi | J. Chamieh | J. Rossi | Habib Merdassi | Joseph Chamieh
[1] A. Müllertz,et al. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels , 2014, The AAPS Journal.
[2] L. Cipelletti,et al. Determination of individual diffusion coefficients in evolving binary mixtures by taylor dispersion analysis: application to the monitoring of polymer reaction. , 2010, Analytical chemistry.
[3] M. Leser,et al. Transitions in the internal structure of lipid droplets during fat digestion , 2011 .
[4] C. Porter,et al. In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.
[5] Ben J. Boyd,et al. Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion , 2017, The AAPS Journal.
[6] Dallas B. Warren,et al. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[7] Sow-Hsin Chen,et al. Characterization of colloidal structures during intestinal lipolysis using small-angle neutron scattering. , 2017, Journal of colloid and interface science.
[8] S. Benita,et al. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] F. Carrière,et al. In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14 , 2009, Pharmaceutical Research.
[10] Christopher J. H. Porter,et al. A new in vitro lipid digestion – in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations , 2015, Pharmaceutical Research.
[11] H. Cottet,et al. Taylor dispersion analysis of mixtures. , 2007, Analytical chemistry.
[12] F. Carrière,et al. In Vitro Digestion of the Self-Emulsifying Lipid Excipient Labrasol® by Gastrointestinal Lipases and Influence of its Colloidal Structure on Lipolysis Rate , 2013, Pharmaceutical Research.
[13] Anette Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system. , 2014, Journal of pharmaceutical sciences.
[14] C. Pouton,et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.
[15] A. Müllertz,et al. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations , 2013, Pharmaceutical Research.
[16] Anette Müllertz,et al. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase , 2014, Pharmaceutical Research.
[17] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[18] D. Hauss. Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.
[19] F. Carrière,et al. Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems. , 2012, Therapeutic delivery.
[20] P. Righetti,et al. Use of Taylor-Aris Dispersion for Measurement of a Solute Diffusion Coefficient in Thin Capillaries , 1994, Science.
[21] H. Cottet,et al. On the optimization of operating conditions for Taylor dispersion analysis of mixtures. , 2014, The Analyst.
[22] Christopher J. H. Porter,et al. years of oral lipid-based formulations : Provenance , progress and future perspectives ☆ , 2016 .
[23] Jean-David Rodier,et al. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. , 2008, Biochimica et biophysica acta.
[24] H. Cottet,et al. Size characterization of commercial micelles and microemulsions by Taylor dispersion analysis. , 2015, International journal of pharmaceutics.
[25] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.
[26] D. Fatouros,et al. Clinical studies with oral lipid based formulations of poorly soluble compounds , 2007, Therapeutics and clinical risk management.
[27] Vincent Jannin,et al. Hydrodynamic size characterization of a self-emulsifying lipid pharmaceutical excipient by Taylor dispersion analysis with fluorescent detection. , 2016, International journal of pharmaceutics.
[28] J. Dressman,et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.
[29] B. Bergenståhl,et al. Morphological observations on a lipid-based drug delivery system during in vitro digestion. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] David J Brayden,et al. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials. , 2016, Advanced drug delivery reviews.
[31] M. Kuentz,et al. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life , 2012, Drug development and industrial pharmacy.
[32] Christel A. S. Bergström,et al. 50years of oral lipid-based formulations: Provenance, progress and future perspectives. , 2016, Advanced drug delivery reviews.
[33] B. Griffin,et al. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.
[34] F. Carrière,et al. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.
[35] P. Constantinides,et al. Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects , 1995, Pharmaceutical Research.
[36] A. Joshi,et al. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead , 2015, Drug delivery.
[37] Farooq Ali Khan,et al. Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[38] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.